跳至主要内容
临床试验/NCT01313871
NCT01313871撤回不适用

Cross-sectional Study of Disease Severity and Treatment Patterns of Rheumatoid Arthritis, in Eastern Europe Middle East and North Africa

Merck Sharp & Dohme LLC0 个研究点开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Number of participants with low, moderate, or high disease activity as assessed by the Disease Activity Score using 28 joint counts (DAS28)

研究概览

简要总结

The study will assess the disease severity and treatment patterns of rheumatoid arthritis in Eastern European, Middle Eastern, and North African countries.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of participants with low, moderate, or high disease activity as assessed by the Disease Activity Score using 28 joint counts (DAS28)

时间窗: Day of enrollment (Day 0)

次要结局

  • The number of participants with rheumatoid arthritis visiting participating sites in the course of one year(One year)
  • Number of participants with different degrees of disability as assessed by the Health Assessment Questionnaire (HAQ).(Day of enrollment (Day 0))
  • Number of participants treated with non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDS), corticosteroids, and/or biologics(Day of enrollment (Day 0))

研究者

申办方类型
Industry
责任方
Sponsor

相似试验